Press Releases Quoin Pharmaceuticals, Ltd.
Equities
QNRX
US74907L4095
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.30 USD | -9.33% |
|
-14.81% | -54.77% |
| 12-05 | Top Premarket Decliners | MT |
| 11-11 | Quoin Pharmaceuticals Announces Achievement of Topical Rapamycin Target Loadings for Two Proprietary Delivery Technologies | CI |
Press Releases
Search
11-11 | AQ | |
11-06 | AQ | |
10-30 | AQ | |
10-28 | AQ | |
10-21 | AQ | |
10-13 | AQ | |
10-10 | AQ | |
09-09 | AQ | |
08-21 | AQ | |
08-18 | AQ | |
08-12 | AQ | |
08-07 | AQ | |
07-31 | AQ | |
07-29 | AQ | |
06-26 | AQ | |
06-24 | AQ | |
05-22 | AQ | |
05-20 | AQ | |
05-15 | AQ | |
05-14 | AQ | |
05-13 | AQ | |
05-06 | AQ | |
04-30 | AQ | |
04-10 | AQ | |
04-02 | AQ |
No results for this search
- Stock Market
- Equities
- QNRX Stock
- News Quoin Pharmaceuticals, Ltd.
- Press Releases
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















